RenovaCare (RCAR) Stock Price, News & Analysis

Company Overview

RenovaCare, Inc. is a biotechnology company focused on regenerative medicine and the development of technologies intended to help treat severe skin injuries, including burns. Its principal product candidate is the CellMist System, an investigational platform designed to use a patient’s own skin cells in the treatment of damaged tissue.

The CellMist System is intended to harvest a small sample of healthy skin, prepare the cells in a liquid suspension, and spray them onto a wound using the company’s specialized device. RenovaCare has described the approach as a potential way to support skin regeneration while reducing the amount of healthy skin required for grafting. The technology remains subject to regulatory review and clinical development.

RenovaCare is headquartered in the United States and has conducted development activities and clinical research related to its technology in the U.S. Publicly available information about the company’s current leadership and commercial operations is limited. There is also no indication that the CellMist System is broadly marketed as an approved commercial treatment.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1,372 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:RCAR
• CIK: 1016708
• Web: www.renovacareinc.com
• Phone: (888) 398-0202
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -127.08